ONDINE BIOMEDICAL INC.CDI Cash Flow-to-Debt Ratio
ONDINE BIOMEDICAL INC.CDI cash flow-to-debt ratio. ONDINE BIOMEDICAL INC.CDI (VF5) has a Cash Flow-to-Debt Ratio of -2.61x as of December 2024, meaning its operating cash flow of €-15.49 Million could theoretically repay -3% of its total liabilities (€5.95 Million) in one year. See ONDINE BIOMEDICAL INC.CDI free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ONDINE BIOMEDICAL INC.CDI (2021–2024)
Cash flow-to-debt ratio of ONDINE BIOMEDICAL INC.CDI from 2021 to 2024. Historical debt coverage capacity for ONDINE BIOMEDICAL INC.CDI across 4 annual periods. Also explore how fast is ONDINE BIOMEDICAL INC.CDI growing its equity to track the company's year-over-year net asset growth rate.
ONDINE BIOMEDICAL INC.CDI Cash Flow-to-Debt Ratio by Year (2021–2024)
ONDINE BIOMEDICAL INC.CDI cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for ONDINE BIOMEDICAL INC.CDI. For the full cash flow conversion analysis, see VF5 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.61x | €-15.49 Million | €5.95 Million | ▲ +30.4% |
| 2023 | -3.74x | €-13.65 Million | €3.65 Million | ▼ -12.7% |
| 2022 | -3.32x | €-16.34 Million | €4.92 Million | ▼ -18.6% |
| 2021 | -2.80x | €-12.54 Million | €4.48 Million | — |